Identification of ARHGAP9 as a Key Diagnostic Marker for Abdominal Aortic Aneurysm by Multiomics and Experimental Validation
Human Mutation · 2025
DOI: 10.1155/humu/7230083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Zhe Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Qinghai Province People's Hospital, Xining, Qinghai, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, GTPase-Activating Proteins, Biomarkers. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Abdominal aortic aneurysm (AAA) is a serious vascular condition that significantly endangers the lives of patients. Although there have been improvements in early detection and treatment methods, considerable challenges persist regarding the timely identification and evaluation of risk associated with this disease. Therefore, there is an immediate requirement for novel biomarkers that can enhance the early diagnosis and risk evaluation of AAA, thus allowing for more accurate and individualized medical interventions. In this study, we identified key diagnostic markers for AAA using various machine learning algorithms, and we explored the functions of these genes in AAA through gene enrichment analysis. A diagnostic model for AAA was constructed based on multiple machine learning algorithms, with the random forest algorithm highlighting the central role of ARHGAP9. In vitro experiments confirmed the influence of ARHGAP9 on vascular smooth muscle cells (VSMCs). Our findings indicate that the key genes identified are associated with the immune microenvironment and metabolism in AAA samples. The validated diagnostic model exhibited excellent predictive performance. Knockdown of ARHGAP9 significantly inhibited the proliferative capacity of VSMCs. In conclusion, our results suggest that ARHGAP9 may serve as a diagnostic and therapeutic marker for AAA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Qinghai Province People's Hospital, Xining, Qinghai, China.
- Department of Vascular Surgery, Changhai Hospital, Shanghai, China.
- Department of Vascular Surgery, 967 Hospital of the Joint Logistics Support Force of PLA, Dalian, Liaoning, China.
ORCID-Profile: Zhe Peng, Kun Li, Shile Wu, Baozhang Chen, Xiaonan Wang, Liang Chen, Xinsheng Wang, Hao Zhang, Biao Wu
Zitieren
APA
Peng, Z., Li, K., Wu, S., Chen, B., Wang, X., Chen, L., Wang, X., Zhang, H., & Wu, B. (2025). Identification of ARHGAP9 as a Key Diagnostic Marker for Abdominal Aortic Aneurysm by Multiomics and Experimental Validation. Human Mutation. https://doi.org/10.1155/humu/7230083
Vancouver
Peng Z, Li K, Wu S, Chen B, Wang X, Chen L, et al. Identification of ARHGAP9 as a Key Diagnostic Marker for Abdominal Aortic Aneurysm by Multiomics and Experimental Validation. Human Mutation. 2025. doi:10.1155/humu/7230083
BibTeX
@article{Peng2025,
author = {Peng, Zhe and Li, Kun and Wu, Shile and Chen, Baozhang and Wang, Xiaonan and Chen, Liang and Wang, Xinsheng and Zhang, Hao and Wu, Biao},
title = {Identification of ARHGAP9 as a Key Diagnostic Marker for Abdominal Aortic Aneurysm by Multiomics and Experimental Validation},
journal = {Human Mutation},
year = {2025},
doi = {10.1155/humu/7230083}
}
EUVIMED